Google fined $161.9 million in India over ‘anti-competitive’ Android policies

Google is facing another fine for allegedly misusing its control of Android to suppress competition. CNETreports India’s Competition Commission has fined Google the equivalent of $161.9 million for supposedly giving its Android apps an edge using restrictive terms. The company imposes an “unfair condition” on phone makers by requiring that they preinstall Google apps as…

Psychedelic survival horror Saturnalia is next week’s free Epic Store game

Saturnalia – the striking new survival horror from acclaimed studio Santa Ragione – is free on the Epic Games Store next week, alongside Warhammer 40,000: Mechanicus. Santa Ragione, if you’re unfamiliar, previously released the celebrated likes of MirrorMoon EP and Fotonica, but Saturnalia – which is heavily influenced by the folklore of Sardinia – looks…

Apex Legends teases new hero Catalyst’s ferrofluid abilities in cinematic trailer

Apex Legends’ 15th season, Eclipse, is right around the corner, and the usual promotional blitz is has begun ahead of its 1st November arrival – this time bringing a new cinematic trailer giving a first look at recently revealed new hero Catalyst’s goopy abilities. Catalyst – an “experienced terraformer and defensive conjurer”, and the first…

Amazon is quietly shutting down Fabric.com, one of the largest online fabric stores

Amazon acquired Fabric.com in 2008. | Illustration by Alex Castro / The Verge Crafters, home sewists, and small businesses will soon lose a major online fabric source. Fabric.com, a longtime retailer of fabrics, trims, notions, and other supplies, is shutting down. Since launching in the late ’90s, Fabric.com has been a mainstay for casual crafters…

Big pharma says drug prices reflect R&D cost. Researchers call BS

Enlarge (credit: Mike Kemp/Getty Images) At the end of September, a spot of good news: Relyvrio, a new drug for treating amyotrophic lateral sclerosis—or ALS, a neurological disorder without a cure—was approved in the United States. The ALS community rejoiced; the drug’s authorization was described as a “long-sought victory for patients.” But the next day,…